New York State Common Retirement Fund Purchases 28,650 Shares of Integer Holdings Corporation $ITGR

New York State Common Retirement Fund raised its position in shares of Integer Holdings Corporation (NYSE:ITGR) by 12.0% during the 3rd quarter, Holdings Channel reports. The fund owned 267,613 shares of the medical equipment provider’s stock after purchasing an additional 28,650 shares during the period. New York State Common Retirement Fund’s holdings in Integer were worth $27,652,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of ITGR. Salomon & Ludwin LLC bought a new stake in Integer in the third quarter worth $26,000. Global Retirement Partners LLC grew its stake in shares of Integer by 293.8% in the 3rd quarter. Global Retirement Partners LLC now owns 319 shares of the medical equipment provider’s stock worth $33,000 after buying an additional 238 shares in the last quarter. CWM LLC increased its holdings in shares of Integer by 46.1% in the 2nd quarter. CWM LLC now owns 355 shares of the medical equipment provider’s stock worth $44,000 after buying an additional 112 shares during the last quarter. MAI Capital Management raised its position in shares of Integer by 220.9% during the 2nd quarter. MAI Capital Management now owns 369 shares of the medical equipment provider’s stock valued at $45,000 after buying an additional 254 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its position in shares of Integer by 210.5% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 534 shares of the medical equipment provider’s stock valued at $66,000 after buying an additional 362 shares in the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms recently commented on ITGR. Raymond James Financial reiterated an “outperform” rating and issued a $95.00 price target (down previously from $143.00) on shares of Integer in a research report on Friday, October 24th. Argus lowered Integer from a “buy” rating to a “hold” rating in a research note on Friday, October 24th. Truist Financial boosted their target price on Integer from $86.00 to $95.00 and gave the company a “buy” rating in a research report on Thursday, December 18th. Bank of America lowered Integer from a “buy” rating to a “neutral” rating and set a $87.00 price target on the stock. in a report on Friday, October 24th. Finally, Wells Fargo & Company restated an “equal weight” rating and issued a $80.00 price target (down from $132.00) on shares of Integer in a research report on Friday, October 24th. Four equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Integer has an average rating of “Hold” and a consensus price target of $98.38.

Key Headlines Impacting Integer

Here are the key news stories impacting Integer this week:

• Negative Sentiment: Multiple firms announce a securities-fraud class action against Integer covering investors who bought shares between July 25, 2024 and October 22, 2025; plaintiffs allege misleading statements and seek lead plaintiff appointments. Integer Accused of Misleading Investors — GlobeNewswire
• Negative Sentiment: Numerous plaintiff firms (Rosen, Levi & Korsinsky, Bernstein Liebhard, Pomerantz, et al.) are soliciting lead plaintiff candidates and reminding investors of a February 9, 2026 deadline to file — increasing the likelihood of consolidated litigation and legal costs. Rosen Law Firm Deadline Notice — Newsfile
• Negative Sentiment: Lawyer notices link the litigation to a prior ~32% share plunge that triggered investor losses; that drop is the proximate cause for the suits and is cited repeatedly in firm announcements. Loss Notice: Plummeted 32% — Newsfile

Insiders Place Their Bets

In related news, Director Cheryl C. Capps purchased 1,600 shares of the business’s stock in a transaction dated Thursday, November 6th. The shares were purchased at an average cost of $66.70 per share, for a total transaction of $106,720.00. Following the completion of the acquisition, the director owned 11,702 shares in the company, valued at approximately $780,523.40. This trade represents a 15.84% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Diron Smith purchased 1,116 shares of Integer stock in a transaction that occurred on Friday, November 7th. The stock was bought at an average cost of $67.19 per share, for a total transaction of $74,984.04. Following the purchase, the executive vice president directly owned 7,698 shares in the company, valued at $517,228.62. This trade represents a 16.96% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders own 2.16% of the company’s stock.

Integer Trading Up 0.5%

Shares of NYSE ITGR opened at $86.87 on Friday. Integer Holdings Corporation has a fifty-two week low of $62.00 and a fifty-two week high of $144.76. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.45 and a current ratio of 3.71. The company has a market cap of $3.04 billion, a price-to-earnings ratio of 36.35, a PEG ratio of 0.79 and a beta of 0.78. The business’s 50 day moving average price is $78.46 and its 200-day moving average price is $90.71.

Integer declared that its Board of Directors has approved a share buyback program on Tuesday, November 4th that authorizes the company to buyback $200.00 million in outstanding shares. This buyback authorization authorizes the medical equipment provider to repurchase up to 8.3% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s board believes its stock is undervalued.

Integer Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.